# Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients

> **NCT02540187** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 164 (actual)

## Conditions studied

- Hemophilia

## Interventions

- **OTHER:** blood specimen

## Key facts

- **NCT ID:** NCT02540187
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2016-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02540187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02540187, "Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02540187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*